Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors.

作者: Ronald A. Simon , Donald D. Stevenson

DOI: 10.1016/S1081-1206(10)61277-X

关键词:

摘要:

参考文章(26)
Eustachio Nettis, Roberto Di Paola, Antonio Ferrannini, Alfredo Tursi, Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs Annals of Allergy Asthma & Immunology. ,vol. 88, pp. 331- 334 ,(2002) , 10.1016/S1081-1206(10)62017-0
Eustachio Nettis, Maria C. Colanardi, Antonio Ferrannini, Alfredo Tursi, Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs. Annals of Allergy Asthma & Immunology. ,vol. 94, pp. 29- 33 ,(2005) , 10.1016/S1081-1206(10)61281-1
J. José Fernando Florido, Joaquín Quiralte, Blanca Sáenz de San Pedro, Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions Annals of Allergy, Asthma & Immunology. ,vol. 89, pp. 63- 66 ,(2002) , 10.1016/S1081-1206(10)61912-6
Artur Zembowicz, Lucyna Mastalerz, Malgorzata Setkowicz, Waldemar Radziszewski, Andrzej Szczeklik, Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Archives of Dermatology. ,vol. 139, pp. 1577- 1582 ,(2003) , 10.1001/ARCHDERM.139.12.1577
Donald D. Stevenson, Ronald A. Simon, Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. The Journal of Allergy and Clinical Immunology. ,vol. 108, pp. 47- 51 ,(2001) , 10.1067/MAI.2001.116290
Katharine M. Woessner, Crossreacting drugs and chemicals. Clinical Reviews in Allergy & Immunology. ,vol. 24, pp. 149- 158 ,(2003) , 10.1385/CRIAI:24:2:149
Joaquín Quiralte, Julio Delgado, Blanca Sáenz de San Pedro, Esperanza López-Pascual, Maria A. Nieto, Nancy Ortega, Jose Fernando Florido, José Conde, Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs Annals of Allergy Asthma & Immunology. ,vol. 93, pp. 360- 364 ,(2004) , 10.1016/S1081-1206(10)61395-6
R. M. Garcia-Rodriguez, M. Hinojosa, E. Camacho-Garrido, P. Berges Gimeno, C. Martin Garcia, Celecoxib, safe in NSAID intolerance. Allergy. ,vol. 57, pp. 1085- 1086 ,(2002) , 10.1034/J.1398-9995.2002.23836_7.X
S M Nasser, M Patel, G S Bell, T H Lee, The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. American Journal of Respiratory and Critical Care Medicine. ,vol. 151, pp. 1326- 1330 ,(1995) , 10.1164/AJRCCM.151.5.7735581
S. Krilis, R.P. Gregson, A. Basten, B.A. Baldo, Investigation of the possible involvement of IgE anti-salicyloyl antibodies in patients with urticaria. International Archives of Allergy and Immunology. ,vol. 64, pp. 293- 301 ,(1981) , 10.1159/000232706